恆指升幅擴至逾200點 惟全年虧轉盈阿里健康(00241.HK)逆挫逾7.5%至半年低
恆指在藍籌地產股和兩大濠賭股全部升逾1%-3%,以及舜宇(02382.HK)、港交所(00388.HK)、美團(03690.HK)和獲大摩吹笛看好的海底撈(06862.HK)依次升逾2%-4.5%帶動升幅擴大,最高見29,166,創近一個月高,現造29,124,續升214點或0.7%,成交額562億元。
不過,阿里健康(00241.HK)全年扭虧轉賺3.49億人民幣,維持不派息,股價今早逆市低見20元,創半年低,現造20.15元,逆吐7.6%,為最傷藍籌,成交增至2,653萬股。
阿里健康公布,截至3月止全年業績扭虧轉賺3.49億元人民幣(下同)(上年蝕659萬元),每股盈利2.63分,維持不派息。期內,總收入按年升近62%至155.18億元;毛利按年升62%至36.17億元。集團全年經調整後利潤淨額按年增近2倍至6.307億元人民幣;電商平台業務GMV按年增長加快至47.5%,以「阿里健康」品牌運營的自營藥房之藥品收入佔比提升至64.8%,藥品收入按增速加快至86.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.